Riskpilot← Back to searchSign inGet full accessNaprapatiska Sverige AB
ABActiveOrg 5569435851Övertänger 204Physiotherapy activities · NACE 8695Est. 20135-9 employees
Revenue 2024
SEK 4,4M
-10% vs 2023
EBITDA margin
1.3%
-40% vs 2023
Equity ratio
30.5%
Financial strength
Net profit 2024
SEK 45K
-12% vs 2023
| Revenue | SEK 4,4M | -10% |
| EBITDA | SEK 58K | -40% |
| Net profit | SEK 45K | -12% |
| Total assets | SEK 1,4M | +16% |
| Equity | SEK 427K | -27% |
| Employees | — | — |
Legal name
Naprapatiska Sverige AB
Org number
5569435851
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
26 september 2013
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska berdiva naprapat- och friskvårdsverksamhet samt kurser och utbildning inom dessa områden med inriktning på målgrupperna företag, privatpersoner och organisationer. Även försäljning av produkter inom dessa områden. Bolaget ska även äga och förvalta fast och lös egendom.
Address
Övertänger 204
Phone
+46703930714
Email
peter@naprapatiska.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 567 | 4 420 | 4 492 | 4 872 | 4 364 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −173 | −39 | 286 | 96 | 58 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −173 | −39 | 286 | 96 | 58 |
| Net financials | — | −1 | — | −24 | 1 |
| Profit before tax | −123 | −40 | 286 | 72 | 59 |
| Tax | −0 | −0 | −60 | −21 | −14 |
| Net profit | −123 | −40 | 226 | 51 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 539 | 1 203 | 1 378 | 1 211 | 1 402 |
| Equity | 346 | 306 | 532 | 582 | 427 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 194 | 898 | 847 | 628 | 975 |
| Total debt | 1 194 | 898 | 847 | 628 | 975 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
30.5%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
10.5%
This company
18.4%
Market median
+43% vs market
20202024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20202024
Asset turnover
3.11×
This company
1.12×
Market median
+178% vs market
20202024
Debt / equity
2.28×
This company
0.62×
Market median
-268% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ | Audit | 2020 |
| Former (1) | ||
XC Chief Auditor | Chief Auditor | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapatiska Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Xuan Cuong Tu | Chief Auditor | 0 companies |
| Anders Johan Bergström | Audit | 0 companies |
| Erik Peter Henningsson | Board of Directors | 0 companies |
| Jonas Babak Parandian | Board of Directors | 0 companies |
| Joao Henrique Daniel Ladislau de Sousa Soares | Deputy Board Member | 0 companies |